Pimarane-type Diterpenes Obtained by Biotransformation: Antimicrobial Properties Against Clinically Isolated Gram-positive Multidrug-resistant Bacteria

The present study describes the antimicrobial activity of five pimarane‐type diterpenes obtained by fungal biotransformation against several nosocomial multidrug‐resistant bacteria. Among the investigated metabolites, ent‐8(14),15‐pimaradien‐3β‐ol was the most active compound, with very promising mi...

Full description

Saved in:
Bibliographic Details
Published inPhytotherapy research Vol. 27; no. 10; pp. 1502 - 1507
Main Authors Porto, Thiago S., Simão, Marília R., Carlos, Lucas Z., Martins, Carlos H. G., Furtado, Niege A. J. C., Said, Suraia, Arakawa, Nilton S., dos Santos, Raquel A., Veneziani, Rodrigo C. S., Ambrósio, Sérgio R.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.10.2013
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present study describes the antimicrobial activity of five pimarane‐type diterpenes obtained by fungal biotransformation against several nosocomial multidrug‐resistant bacteria. Among the investigated metabolites, ent‐8(14),15‐pimaradien‐3β‐ol was the most active compound, with very promising minimal inhibitory concentration values (between 8.0 and 25.0 µg mL−1). Time‐kill assays using this metabolite against Staphylococcus aureus (HCRP180) revealed that this compound exerted its bactericidal effect within 24 h at all the evaluated concentrations (8.0, 16.0, and 24.0 µg mL−1). When this metabolite was associated with vancomycin at their minimal bactericidal concentration values, the resulting combination was able to drastically reduce the number of viable strains of S. aureus within the first 6 h, compared with these chemicals alone. The checkerboard assays conducted against this microorganism did not evidence any synergistic effects when this same combination was employed. In conclusion, our results point out that ent‐8(14),15‐pimaradien‐3β‐ol is an important metabolite in the search for new effective antimicrobial agents. Copyright © 2012 John Wiley & Sons, Ltd.
Bibliography:istex:0ED50CD9CC2213A45AD75C90A77636389E740E4A
ark:/67375/WNG-TT96HR45-Z
ArticleID:PTR4887
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0951-418X
1099-1573
DOI:10.1002/ptr.4887